Organizational aspects of implementation pharmacogenetic testing in the treatment and prevention practice multidisciplinary hospital
Abstract
Today, we know about 900 genetic tests which results are used extensively in medical practice worldwide. In addition to the clinical relevance, genetic diagnosis has a positive impact in economic component of patient care. In this research will discuss about some aspects of pharmacogenetics laboratory creation, and its integration into the workflow of the diversified department of the municipal hospital in Moscow.
About the Authors
I. V. Kukes
Первый МГМУ им И.М. Сеченова, Москва
Россия
Россия
V. N. Shan
Россия
M. K. Alimuradov
Россия
A. V. Semenov
Городская клиническая больница №23, Москва 1 2
Россия
Россия
V. M. Ruseykin
Городская клиническая больница №23, Москва 1 2
Россия
Россия
D. A. Sychev
Центр клинической фармакологии НЦЭСМП Минздравсоцразвития РФ, Москва
Россия
Россия
References
1. Тарифы медико-экономических стандартов для оплаты по системе обязательного медицинского страхования, актуальные на ноябрь 2011 года (последняя версия).
2. Eckman M.H., Rosand J., Greenberg S.M., Gage B.F. Costeffectiveness of using pharmacogenetic information in warfarin dosing for patientswithnonvalvularatrial fibrillation. // Ann Intern Med. 2009. Jan 20;150(2):73-83.
3. Eriksson N., Wadelius M. Prediction of warfarin dose: why, when and how? // Pharmacogenomics March 2012. Vol. 13. No. 4. Pages 429-440. DOI 10.2217/pgs.11.184 (doi:10.2217/ pgs.11.184).
Review
For citations:
Kukes I.V., Shan V.N., Alimuradov M.K., Semenov A.V., Ruseykin V.M., Sychev D.A. Organizational aspects of implementation pharmacogenetic testing in the treatment and prevention practice multidisciplinary hospital. Journal Biomed. 2012;1(4):124-126. (In Russ.)
Views:
349
JATS XML
Email this article 
